Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Yahoo (Ronran post)
It makes perfect since. The problem here is everyone keeps assuming only one party has something to lose. Certainly the J's would agree to an NDA if it meant, among other things, walking away with greatly reduced license cost and keeping quiet about it. As my relative kept saying to me, "are you sure it was the defendants asking for an NDA?" He kept telling me to remember both parties have their own interest to protect. I agree completely with Ronrans post. The rash of signing afterward make his scenario even more plausible. You really wonder why TPL/PTSC wanted an NDA? Remember this has been and will continue to be, a long drawn out game of strategy. Every single negotation, to some degree, is like starting over. It's a fresh new player, whom Alliacense it trying to extract the most value. I personally believe now that the April numbers are out, the signings will drop off dramatically until the USPTO results. To some degree Alliacenses "poker hand" has now been shown. Only the USPTO decision can up the ante.
Share
New Message
Please login to post a reply